Targeting 5-Hydroxytryptamine receptor 1A in portal vein to decrease portal hypertension. Zhu CP, Liu SQ, Wang KQ, Xiong HL, et al. Gastroenterology 2024 Jun 19:S0016-5085(24)05062.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu CP, Liu SQ, Wang KQ, Xiong HL, et al. Targeting 5-Hydroxytryptamine receptor 1A in portal vein to decrease portal hypertension. Gastroenterology 2024 Jun 19:S0016-5085(24)05062.
PMID: 38906512